Reckitt Benckiser Group (LON:RB) had its target price decreased by research analysts at DZ Bank from GBX 6,500 ($84.93) to GBX 6,000 ($78.40) in a research report issued on Thursday, October 31st, ThisIsMoney.Co.Uk reports. The firm currently has a “hold” rating on the stock. DZ Bank’s target price points to a potential upside of 1.52% from the company’s previous close.
A number of other research firms have also recently weighed in on RB. Bryan, Garnier & Co reaffirmed a “neutral” rating and set a GBX 6,870 ($89.77) price target (up previously from GBX 6,800 ($88.85)) on shares of Reckitt Benckiser Group in a report on Tuesday, July 30th. Barclays cut their price target on Reckitt Benckiser Group from GBX 7,500 ($98.00) to GBX 6,700 ($87.55) and set an “overweight” rating on the stock in a report on Thursday, October 24th. Deutsche Bank reaffirmed a “buy” rating on shares of Reckitt Benckiser Group in a report on Wednesday, October 23rd. Morgan Stanley reaffirmed an “overweight” rating on shares of Reckitt Benckiser Group in a report on Monday, July 15th. Finally, Sanford C. Bernstein set a GBX 7,600 ($99.31) price target on Reckitt Benckiser Group and gave the company a “buy” rating in a report on Friday, October 18th. Four investment analysts have rated the stock with a sell rating, four have assigned a hold rating and ten have issued a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of GBX 6,803.89 ($88.90).
LON RB traded down GBX 49 ($0.64) during trading hours on Thursday, reaching GBX 5,910 ($77.22). The company’s stock had a trading volume of 716,737 shares, compared to its average volume of 1,720,000. The company has a current ratio of 0.59, a quick ratio of 0.43 and a debt-to-equity ratio of 85.08. The business has a 50-day simple moving average of GBX 6,094.38 and a 200 day simple moving average of GBX 6,236.48. Reckitt Benckiser Group has a 52 week low of GBX 5,510 ($72.00) and a 52 week high of GBX 6,778 ($88.57). The stock has a market cap of $42.03 billion and a PE ratio of 29.67.
About Reckitt Benckiser Group
Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.
See Also: Why do companies engage in swaps?
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.